Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Videos
Webinars
Press Releases
Whitepapers
Advertising
Digital Pathology: Page 28
Proscia raises $37M in Series C financing
By
LabPulse.com staff writers
The round includes participation from Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital as well as existing investors including Scale Venture Partners, Hitachi Ventures, Robo Global, Emerald Development Managers, and Razor's Edge Ventures.
June 13, 2022
CDx Diagnostics, Avalon ink in-network lab agreement
By
LabPulse.com staff writers
The agreement makes CDx's diagnostic platform, WATS3D, available to the 565,000 members of BCBS of South Carolina, including all of its commercial and Medicare Advantage plans.
June 13, 2022
Nanomix receives IVDR certification for eLab analyzer
By
LabPulse.com staff writers
The analyzer is part of its Nanomix eLab system, a rapid, quantitative detection platform that can perform numerous in vitro diagnostic assays. The system uses a proprietary nanobiosensor with multiple detection electrodes to generate multiple electrochemical assay results from a single patient sample. It consists of a handheld analyzer and disposable cartridge.
June 13, 2022
BD partners with Mayo Clinic on post-market data analysis
By
LabPulse.com staff writers
Mayo Clinic Platform_Discover comprises datasets from 10 million patients including structured and unstructured data, images, 1.2 billion lab test results, 3 million echocardiograms, and more than 640 million clinical notes.
June 12, 2022
FDA clears Scopio Labs hematology analysis platform
By
LabPulse.com staff writers
Tel Aviv, Israel-based Scopio said the X100HT is a full-field digital imaging and artificial intelligence (AI)-enabled platform that combines high throughput with high resolution for hematological analysis.
June 9, 2022
PathAI to present AI pathology studies at London liver congress
By
LabPulse.com staff writers
The presentation abstracts describe the use of a new machine learning-enabled continuous scoring system for nonalcoholic steatohepatitis (NASH), the firm said.
June 8, 2022
Karius, Capstone Health widen access to liquid biopsy test
By
LabPulse.com staff writers
According to Karius, the new partnership will also broaden access to microbial cell-free metagenomics technology used in the liquid biopsy-based, lab-developed test.
June 8, 2022
Proscia nabs CE Mark under IVDR for digital pathology platform
By
LabPulse.com staff writers
Concentriq Dx is designed to support laboratories in realizing pathology's artificial intelligence (AI)-enabled future, Proscia said, adding that its platform enables lab networks to unify pathology operations and eliminate geographic silos.
June 7, 2022
StatLab acquires histology and cytology manufacturer CellPath
By
LabPulse.com staff writers
Financial terms of the deal were not disclosed.
June 7, 2022
Biodesix obtains Medicare coverage for lung nodule test
By
LabPulse.com staff writers
According to Biodesix, Nodify CDT measures seven autoantibodies associated with tumor antigens to help providers detect lung cancer across all histologies and stages.
June 6, 2022
Applied DNA Sciences, EvviVax announce cancer vaccine data
By
LabPulse.com staff writers
The firms noted that the study, published on June 6, found that two LinearDNA therapeutic cancer vaccines elicited a strong immune and specific antitumor response in mouse models using electro-gene-transfer as the delivery method.
June 6, 2022
AACC expresses concern about rush to pass VALID Act
By
LabPulse.com staff writers
The bill would limit patient access to laboratory-developed tests and the diagnoses these tests enable.
June 6, 2022
Previous Page
Page 28 of 179
Next Page